Articles tagged with Bacterial Infections
Researchers have uncovered a new mechanism of antibiotic resistance in Group A Streptococcus bacteria, making antibiotics ineffective and potentially leading to poor outcomes. The discovery highlights the complexity of understanding AMR and emphasizes the need for rapid diagnostic tools and therapeutics.
Researchers at the University Hospital Bonn have discovered a new function of CRISPR/Cas9 gene scissors, which produce small signal molecules that bind to proteins, activating an emergency response. This discovery opens up new possibilities for treating diseases using CRISPR technology.
Researchers at Karolinska Institutet have identified the most common bacteria found in severe oral infections, shedding new light on the association between oral health and systemic diseases. The study found that certain bacterial infections can spread to other parts of the body, highlighting the importance of understanding the role of...
A recent study found that superbugs in the environment rarely transmit to humans, contrary to previous fears. The researchers discovered high levels of antimicrobial-resistant bacteria in livestock, pets, and environmental samples, but surprisingly little overlap between hospital and environmental strains.
A new study by CHOP researchers found that antibiotic-resistant Enterococcus enhances C. difficile virulence by modulating the gut environment, increasing toxin production and nutrient supply. This interaction supports increased colonization and persistence of C. difficile in the gut.
A new study by Weill Cornell Medicine investigators finds that Enterococcus faecalis enhances its protective outer layer to resist natural immune defenses and antibiotics. The research suggests possible new ways to target these bacterial infections.
Researchers identify unique chemical signal allowing ancient TB bacteria to evade immune system and spread beyond lungs. The 'mobile factor', called EsxM, allows the bacteria to infect macrophages more easily, leading to bone infections in six people.
The risk of death from infective endocarditis (IE) among young US residents aged 15-44 years has doubled in the last two decades. IE cases among younger patients and those who inject drugs have increased, with mortality rates increasing by 50%.
Urban-living Indigenous children and young people in high-income countries are disproportionately affected by atopic dermatitis and bacterial skin infections, which can lead to serious complications. This systematic review highlights the need for co-designed research with Indigenous communities to address these health inequities.
Co-infection with gut parasites increases shedding of respiratory bugs like Bordetella bacterium, leading to higher probability of onward transmission. This study in rabbits has broad implications for human populations and suggests targeting treatment of helminths could be an effective way to reduce disease outbreaks.
Research suggests that antibiotics used in ovarian cancer treatment can accelerate cancer progression and lower survival rates. Reintroducing healthy gut bacteria may slow down cancer growth and restore sensitivity to chemotherapy.
A new AI technology has been developed to automatically diagnose lung diseases such as tuberculosis and pneumonia, freeing up radiographers and reducing waiting times for test results. The system, which uses X-ray imaging and deep learning algorithms, achieved a 98% accuracy rate during extensive testing.
A new treatment option for multi-resistant bacteria has been identified by a UNIGE team, which uses the drug edoxudine to weaken the defence mechanisms of Klebsiella pneumoniae, making it easier to eliminate. This approach could be a game-changer in the fight against antibiotic resistance.
A new study by Ochsner pharmacist Kevin Lin suggests that oral cephalosporins are as safe and effective as fluoroquinolones for treating acute kidney infections. The study's findings support the use of narrower-spectrum antibiotics to reduce antimicrobial resistance, a growing concern in healthcare.
The study found that protein kinase CK2 plays a key role in regulating CD8+ T cell activation, metabolic reprogramming and differentiation during infection by the intracellular pathogen Listeria monocytogenes. In mouse models, deletion of the CK2α catalytic subunit impaired CD8+ T cell function.
A new study found that COVID-19 infection directly interferes with the healthy balance of microbes in the gut, further endangering patients. The research revealed that antibiotic-resistant species can escape into the bloodstream, putting patients at greater risk for life-threatening secondary infections.
Researchers at Osaka University have discovered the spatial characteristics of an efflux pump that helps bacteria resist antibiotics. By analyzing a specific inhibitor's binding site, they found bulky mutations can prevent the inhibitor from working, offering hope for developing new countermeasures to combat antibiotic resistance.
Researchers have developed a way to load potent antibiotics like Polymyxin B into red blood cells, allowing them to selectively target and kill drug-resistant bacteria. This technology could help address the ongoing antibiotic resistance crisis and deliver drugs more quickly and directly to specific sites in the body.
Researchers from Johannes Gutenberg University Mainz developed ceria nanoparticles to silence bacteria by modifying signaling molecules, preventing biofilm formation. This approach mimics nature's defense system and has potential for creating antibacterial surfaces without resistance.
New research reveals a relationship between virus concentration and organic carbon in wastewater treatment plant effluents. The study found that viruses can affect the concentration of organic carbon, leading to potential negative impacts on aquatic ecosystems nearby.
A randomized clinical trial found that applying topical antibiotics to the upper digestive tract can improve survival rates in mechanically ventilated intensive care patients. The study, published in JAMA, also showed a significant reduction in new hospital-acquired infections.
A new drug combination of cefepime and enmetazobactam has been found to be more effective in treating complicated urinary tract infections and acute pyelonephritis than a standard treatment. The study showed that the new combination was successful in treating 79% of patients, compared to 58.9% for the conventional treatment.
Researchers analyzed S. lugdunensis isolates from pediatric patients and found that skin infections were a common source (68%), while CNS infections linked to VP shunts were also significant. Flucloxacillin was identified as effective against the bacterium.
Researchers developed a small peptide that can directly kill bacteria and trigger plant defense tactics to prevent diseases like almond leaf scorch. The treatment significantly reduces pathogen population and disease symptoms, making it a promising approach for sustainable crop protection.
Researchers have developed a novel method for antibiotic resistance testing that can analyze bacterial cells in real-time, allowing for faster identification of susceptible and resistant bacteria. This breakthrough technology has the potential to transform microbial screening in clinical and research labs.
Researchers highlight climate-sensitive dermatological manifestations initiated or exacerbated by floods, wildfires, and extreme heat events. These events disproportionately affect marginalized populations, exacerbating existing health disparities.
Researchers have successfully blocked the adhesion mechanism of Bartonella henselae bacteria, preventing cell infection. The discovery offers a promising new approach to combat highly resistant infectious agents like Acinetobacter baumannii.
Scientists have developed an enzyme that effectively breaks down signaling molecules used by bacteria to produce biofilms. The enzyme, LrsL, has exceptional efficacy in suppressing biofilm formation by Pseudomonas aeruginosa, a bacterium known for causing hospital-acquired infections.
A study by Osaka University researchers has revealed the molecular details of how Vibrio cholerae secretes its colonization factor TcpF. The mechanism involves the Toxin-coregulated pilus (TCP) system, which allows the bacterium to colonize the human intestine and initiate infection.
The WHO European Region sees high mortality rates due to antimicrobial resistance, with countries implementing national actions plans showing lower AMR burden. Developing new treatments and improving hygiene are crucial strategies to combat this growing health threat.
A new platform has been created using 214,000 microbiome samples to track antibiotic-resistant bacteria globally. The data can be used to tailor guidelines on combating resistance in different regions.
A new testing method for tuberculosis may make diagnosis easier by using saliva instead of sputum, which can be unpleasant and impractical. The method has shown high sensitivity in detecting the bacteria that causes TB, but its effectiveness in people with HIV is less clear.
A new study published in the European Respiratory Journal found that early treatment with anti-anaerobic antibiotics can deplete gut anaerobes and lead to worse clinical outcomes. The research suggests that these 'good bugs' protect against pneumonia, organ failure, and mortality.
Scientists at the University of Bath have discovered a novel polyamine that destroys MRSA superbug Staphylococcus aureus by disrupting its cell membrane, rendering it susceptible to antibiotics. The compound is also effective against biofilm and has shown promise as a potential new treatment option for antibiotic-resistant infections.
Researchers at the University of Basel have discovered a new antibiotic, Dynobactin, effective against resistant Gram-negative bacteria. The compound blocks bacterial membrane protein BamA, preventing its job and killing the bacteria. This finding offers a boost to antibiotics research and could lead to more effective drugs.
Researchers have identified a new antifungal antibiotic named solanimycin produced by a pathogenic potato bacterium. The compound shows efficacy against various fungi, including Candida albicans, and has potential for both agricultural and clinical applications.
A clinical trial is underway to evaluate the safety and efficacy of bacteriophage therapy in adults with cystic fibrosis who carry Pseudomonas aeruginosa. The trial aims to reduce bacterial load in the lungs using a phage cocktail that targets specific bacteria, providing a potential new treatment for difficult-to-treat infections.
Tagbo Niepa's research aims to capture and store a person's healthy gut microbiome, then restore balance when ill. The technology has the potential to revolutionize illness treatment, especially for diseases like C. diff infection.
Researchers at La Jolla Institute for Immunology have discovered a rare T cell defect tied to the risk of developing MAC disease. People with this defect have fewer specialized Th1* cells, which robs them of an effective immune response to MAC bacteria.
Researchers found that Carbapenemase-producing Enterobacteriaceae (CPE) colonizes the gut without symptoms, depleting key bacteria and leaving tell-tale marks. Rebalancing gut bacteria may help promote CPE decolonization and prevent antibiotic resistance transmission.
Dr. Cynthia Nau Cornelissen receives $4.9 million NIH grant to explore Neisseria gonorrhoeae metal transporters that disrupt nutritional immunity, a key process preventing microbial growth and infectivity. The research aims to develop new therapeutics against 'superbug' strains and potentially create a protective vaccine.
Researchers found pre-existing differences in gut bacteria between people with and without HIV, including decreased Bacteroides species and increased Megasphaera elsdenii. These changes were present even before infection occurred, suggesting a potential link between gut microbiome and HIV susceptibility.
A new study conducted by researchers from Aarhus University and Aarhus University Hospital shows that fecal transplantation is an effective cure for life-threatening intestinal infections, with a cure rate of over 90%. The treatment was found to be far superior to the standard treatment, which typically consists of antibiotics.
Researchers used Raman spectroscopy to identify and analyze Escherichia coli persister cells, finding they have enhanced metabolic activities despite being in a dormant state. This new understanding could lead to the development of novel therapeutic strategies.
The UK's Biotechnology and Biological Sciences Research Council has awarded £19 million to five world-class teams investigating bold ideas in bioscience. These projects will advance our understanding of fundamental rules of life, with potential implications for agriculture, health, biotechnology, and the green economy.
Researchers at the University of California San Diego developed microscopic robots called microrobots that can swim around in the lungs and deliver medication. The microrobots safely eliminated pneumonia-causing bacteria in mice, resulting in 100% survival rates, whereas untreated mice died within three days.
Research at Karolinska Institutet shows that people with diabetes have lower levels of psoriasin, a key peptide that weakens the bladder's protective barrier function. This increases the risk of urinary tract infections. Oestrogen therapy may help regulate the immune response to UTIs in patients with diabetes.
A new study published in PLOS Medicine found that people with hospital-treated infections in early- and mid-life had a higher risk of developing Alzheimer's disease (AD) and Parkinson's disease (PD). The research analyzed data on over 291,000 cases and matched controls to identify the association between infections and neurodegenerativ...
A study led by Singapore scientists found that Neisseria, a genus of bacteria once considered harmless, can cause infections in patients with bronchiectasis, asthma, and COPD. The research team identified a specific subgroup of Neisseria called N. subflava as the main culprit behind worsening disease outcomes.
Researchers at Imperial College London discovered a 'silent' mutation in bacteria that helps them evade antibiotics. The mutation alters the structure of an mRNA intermediate, preventing ribosomes from producing protein, and has arisen independently several times globally.
Researchers at Duke University have discovered a protein called GarD that cloaks Chlamydia bacteria from the host cell's immune system, allowing it to evade detection and elimination. Mutating this protein makes the bacteria vulnerable to destruction, offering new avenues for treatment.
Scientists at Aston University developed a new treatment combining manuka honey with the widely used antibiotic amikacin to treat drug-resistant lung infections. The study found that this combination improved bacterial clearance and reduced side effects, benefiting patients with cystic fibrosis.
A machine-learning model developed at Mass Eye and Ear accurately diagnosed pediatric ear infections at a rate 30 percent higher than doctors surveyed. The model achieved 95% accuracy in diagnosing an ear infection from test images, surpassing the average clinical accuracy of 65%.
A new American Heart Association statement highlights the need for specialized care in people who inject drugs, a population with a complex approach to manage potentially deadly heart infections. The standard treatment includes six weeks of intravenous antibiotics, but alternative regimens and oral antibiotics may help complete treatment.
A study by Taiwanese researchers found that patients with atherosclerosis are at higher risk for life-threatening vascular infections from non-typhoidal Salmonella bacteremia. The study suggests the use of a scoring system to predict infection risk and identifies interleukin-1 beta as a potential biomarker.
Research at Karolinska Institutet reveals the glymphatic system malfunctions during bacterial meningitis, causing a buildup of toxic garbage that damages brain cells. The study found increased signs of neuroinflammation and neuronal damage in rats infected with Streptococcus pneumoniae.
Researchers found that intracellular bacteria known as symbionts protect their host amoebae against giant viruses. This discovery suggests a positive effect of the bacterial symbionts on the ecosystem, influencing the flow of nutrients in food webs and potentially impacting ecosystem dynamics.
Researchers developed a light-based therapy, photodynamic therapy (aPDT), to combat antibiotic-resistant bacteria. The treatment showed promise in weakening bacteria, allowing lower doses of current antibiotics to effectively eliminate them.
A new class of light-activated hemithioindigo molecules developed by Rice University scientists kill specific Gram-positive bacteria and their biofilms. The molecules induce reactive oxygen species that chemically attack and destroy drug-resistant cells, offering a safer alternative to conventional antibiotics.
A mass drug administration (MDA) program with ivermectin is being delivered on a mass scale in the Solomon Islands, a world first. The program aims to prevent scabies, a contagious and itchy skin condition that affects a third of the nation's children.